|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 21, 2012 ) Boca Raton, FL --- Spaulding Clinical, located in West Bend, Wisconsin, provides clinical research services and ECG management solutions for medical markets globally. They were selected for the segment on Next-Generation Solutions for Cardiovascular Disease, based on the recently released Spaulding iQ™, a revolutionary mHealth 12-lead diagnostic electrocardiograph. About the size of a hockey puck and weighing just 3 ounces, it utilizes a microphone and voice-print biometrics to identify the patient and records up to 5 minutes of 12-lead ECG data compared to the limited 10 second samples from conventional ECG machines. Spaulding has recently submitted a 510k application for the addition of Bluetooth wireless capabilities and applications for both Android® and Apple® smartphones/tablets for their new product, the Spaulding iQ™ MD electrocardiograph. This device is designed to provide an easy-to-use, cost-effective, diagnostic 12-lead assessment of high risk cardiovascular patients in their home which helps maintain quality of life for the patient while decreasing the cost of care and extending the reach of busy physicians.
There are 16.8 million people with coronary heart disease and 14.4 million people with cardiac dysrhythmias in the US alone. More than 10 million people suffer from cardiac-related chest pain and this year 6 million Americans with chest pain will seek medical attention at hospital emergency departments. Financially, cardiovascular disease is responsible for 17% of the national health expenditures and is expected to triple from $273 billion to $819 billion by 2030.
“As the growing elderly population increases, hospital-quality access and affordability of health care are becoming significant concerns for us all. We foresee the Spaulding iQ™MD electrocardiograph playing a major role in the management of cardiovascular patients, right in their homes,” states Randol Spaulding, CEO and Founder of Spaulding Clinical. This will become even more important as hospital Medicare reimbursements, for patients readmitted within 30 days of discharge, are impacted beginning later this year. Mr. Spaulding and Dr. Jay Mason, cardiologist and Chief Medical Officer, Spaulding Clinical, will be discussing strategies utilizing the Spaulding iQ to expand access to quality healthcare for high-risk cardiovascular patients in their home.
Spaulding Clinical Research is passionate in their pursuit of ingenious mHealth technology that will save time and money for their clients and heroic in their ambitions to ensure the health and safety of all patients. Spaulding Clinical Research strives to be a trusted partner in creating a world of safer drugs and a technology leader in making hospital-quality cardiac care affordable and accessible to all God’s children.
To learn more about Spaulding Clinical please visit: www.spauldingclinical.com
About 21st Century Business
21st Century Business is an award winning television series produced by Multi-Media Productions. The show features companies providing business viewers an in-depth opportunity to find solutions within many industries globally.
21st Century Business airs on CNBC and the Fox Business Network to over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The show can also be viewed through video on demand via http://www.21cbtv.com. The series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.21cbtv.com.
MultiMedia Productions
Gila Stern
561-988-9449 x269
gstern@mmpusa.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
